Sunday, October 22nd | 2 Heshvan 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
July 27, 2015 9:33 am

Israel’s Teva Pharmaceuticals to Purchase Allegran Generics for $40.5 Billion

avatar by News Editor

Email a copy of "Israel’s Teva Pharmaceuticals to Purchase Allegran Generics for $40.5 Billion" to a friend
Israel's Teva will acquire Allergan for $40.5 billion. Photo: Screenshot.

Israel’s Teva pharmaceuticals will acquire Allergan for $40.5 billion. Photo: Screenshot.

Allergan President and CEO Brent Saunders said Monday the sale of its generics business would allow the company to double down on its higher margin, higher growth branded drugs business.

Saunders spoke on CNBC’s Squawk Box after Israel’s Teva Pharmaceutical announced plans to purchase Dublin-based Allergan’s generic pharmaceuticals business for $40.5 billion.

Read full story at CNBC.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner

Algemeiner.com